Analysis of Suicide Dynamics in Link to the COVID-19 Pandemic

NCT06084143 | Unknown

• 1 other identifier: 9026
• Study Type: observational
• Target: 2,500
• Locations: 1 country
• Sites: 1

Brief Summary

Covid is a virus that first appeared in China in 2019 and was quickly described as a pandemic virus by its globalized nature. The unprecedented occurrence of the virus has led to several health and restrictive government measures. The Covid-19 pandemic and health measures have been able to contribute to the deterioration of the mental health of citizens as it has already been observed during the former pandemic context (Sars covid in 2003 in China or the Spanish flu). Among the consequences of a negative impact on mental health, investigators assume that there is an increase in transitions to the completed suicidal act. However, current studies and observations tend to note that there has been no major change in the dynamics of successful suicides during the Covid period. However, there are biases in the studies conducted: some suicide deaths may have been hidden and not reported as such, due to several factors. For example, the measure of the evolution of suicide attempts that was most often made by the measure of the evolution of the number of hospitalizations for this reason can be a source ofestimate whether people who did this gesture were not hospitalized after a visit to the emergency room or if they gave up attending because of the pandemic. Moreover, suicide deaths are more difficult to report as such when they occur at home than after hospitalization. It is therefore interesting to study the dynamics of suicide during this health crisis retrospectively based on data from the Strasbourg Institute of Forensic Medicine containing the census of the Alsace region, which was hit hard by the pandemic.

Conditions

COVID-19

Keywords

Covid-19; Suicide

Outcome Measures

Primary Outcomes (1)

• Suicide rates before and after the Covid-19 pandemic

  from January 1, 2018 to December 31, 2021

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult patient died between 01/01/2018 and 12/31/2021

You may qualify if:

• Adult patient
• Died between 01/01/2018 and 12/31/2021
• Absence of opposition from the patient expressed in writing during his lifetime to the reuse of his personal data for scientific research purposes.

You may not qualify if:

• Presence of opposition by the patient expressed in writing during his lifetime to the reuse of his personal data for scientific research purposes.

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Service de Psychiatrie - CHU de Strasbourg - France

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

COVID-19; Suicide

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Self-Injurious Behavior; Behavioral Symptoms; Behavior

Central Study Contacts

Philippe MEYER, MD

CONTACT

33 3 88 11 16 48; philippe.meyer@chru-strasbourg.fr

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 10, 2023
• First Posted: October 16, 2023
• Study Start: July 21, 2023
• Primary Completion: July 21, 2024
• Study Completion: July 21, 2024
• Last Updated: October 16, 2023

Record last verified: 2023-07

Locations

FR (1)